← Back to Screener
SeaStar Medical Holding Corporation Common Stock (ICU)
Price$4.63
Favorite Metrics
Price vs S&P 500 (26W)-35.32%
Price vs S&P 500 (4W)78.85%
Market Capitalization$16.77M
All Metrics
Book Value / Share (Quarterly)$2.71
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-3.54
Price vs S&P 500 (YTD)70.86%
Gross Margin (TTM)95.71%
Net Profit Margin (TTM)-984.60%
EPS (TTM)$-8.26
10-Day Avg Trading Volume0.15M
EPS Excl Extra (TTM)$-8.26
EPS (Annual)$-5.86
ROI (Annual)-111.05%
Gross Margin (Annual)95.71%
Cash / Share (Quarterly)$3.12
Revenue Growth QoQ (YoY)526.87%
ROA (Last FY)-85.82%
EBITD / Share (TTM)$-5.89
Operating Margin (TTM)-986.47%
Cash Flow / Share (Annual)$-3.54
P/B Ratio1.61x
P/B Ratio (Quarterly)0.83x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)4.31x
Net Interest Coverage (TTM)-28.56x
ROA (TTM)-106.42%
EPS Incl Extra (Annual)$-5.86
Current Ratio (Annual)3.63x
Quick Ratio (Quarterly)3.26x
3-Month Avg Trading Volume0.14M
52-Week Price Return-67.19%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$-0.86
P/S Ratio (Annual)13.59x
Asset Turnover (Annual)0.09x
52-Week High$13.40
EPS Excl Extra (Annual)$-5.86
26-Week Price Return-26.57%
Quick Ratio (Annual)3.26x
13-Week Price Return50.54%
Total Debt / Equity (Annual)0.05x
Current Ratio (Quarterly)3.63x
Enterprise Value$5.319
Asset Turnover (TTM)0.11x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-984.36%
Cash / Share (Annual)$3.12
3-Month Return Std Dev116.43%
Net Income / Employee (TTM)$-1
ROE (Last FY)-116.65%
Net Interest Coverage (Annual)-23.18x
EPS Basic Excl Extra (Annual)$-5.86
Receivables Turnover (TTM)7.07x
Total Debt / Equity (Quarterly)0.05x
EPS Incl Extra (TTM)$-8.26
ROI (TTM)-182.20%
P/S Ratio (TTM)13.59x
Revenue / Share (Annual)$0.60
Tangible BV / Share (Annual)$-0.65
Price vs S&P 500 (52W)-102.28%
Year-to-Date Return75.00%
5-Day Price Return-0.24%
EPS Normalized (Annual)$-5.86
ROA (5Y Avg)-522.93%
Net Profit Margin (Annual)-984.60%
Month-to-Date Return12.90%
EBITD / Share (Annual)$-5.87
Operating Margin (Annual)-986.63%
LT Debt / Equity (Annual)0.03x
EPS Basic Excl Extra (TTM)$-8.26
P/B Ratio (Annual)0.83x
Pretax Margin (TTM)-984.36%
Book Value / Share (Annual)$2.71
Price vs S&P 500 (13W)47.67%
Beta-1.04x
Revenue / Share (TTM)$0.34
ROE (TTM)-188.47%
52-Week Low$2.07
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
4.00
4.00
4.00
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
ICUSeaStar Medical Holding Corporation Common Stock | 13.59x | — | 95.71% | -986.47% | $4.63 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
SeaStar Medical develops extracorporeal therapies designed to reduce hyperinflammation and its damaging effects on vital organs. The company's proprietary platform targets the inflammatory cells and cytokines that drive systemic immune responses and tissue damage. It operates a single Device segment focused on commercializing these therapeutic solutions.